Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04059094 |
| Consolidated Lead Sponsor | Boehringer Ingelheim |
| Therapeutic Condition Cohort | Respiratory and Pulmonary |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 52 participants (ACTUAL) |
| Registered Start Date | 2019-09-16 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Nemours Children's Hospital | Orlando, FL | Open Hospital Dossier -> |
| Medical University of South Carolina | Charleston, SC | Open Hospital Dossier -> |
| UT Southwestern Simmons Cancer Center | Dallas, TX | Open Hospital Dossier -> |
| University of Washington | Seattle, WA | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Boehringer Ingelheim across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.